128 related articles for article (PubMed ID: 17724043)
21. UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-specific analyses.
Farrington K; Udayaraj U; Gilg J; Feehally J
Nephron Clin Pract; 2009; 111 Suppl 1():c13-41. PubMed ID: 19542695
[TBL] [Abstract][Full Text] [Related]
22. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
Boddana P; Caskey F; Casula A; Ansell D
Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
[TBL] [Abstract][Full Text] [Related]
23. UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses.
Farrington K; Hodsman A; Casula A; Ansell D; Feehally J
Nephron Clin Pract; 2009; 111 Suppl 1():c43-68. PubMed ID: 19542705
[TBL] [Abstract][Full Text] [Related]
24. Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses.
Gilg J; Castledine C; Fogarty D
Nephron Clin Pract; 2012; 120 Suppl 1():c1-27. PubMed ID: 22964563
[TBL] [Abstract][Full Text] [Related]
25. UK Renal Registry 18th Annual Report (December 2015) Chapter 5: Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2014: National and Centre-specific Analyses.
Steenkamp R; Rao A; Fraser S
Nephron; 2016; 132 Suppl 1():111-44. PubMed ID: 27115403
[TBL] [Abstract][Full Text] [Related]
26. UK Renal Registry 13th Annual Report (December 2010): Chapter 7: the relationship between the type of vascular access used and survival in UK RRT patients in 2006.
Castledine C; van Schalkwyk D; Feest T
Nephron Clin Pract; 2011; 119 Suppl 2():c135-40. PubMed ID: 21894030
[TBL] [Abstract][Full Text] [Related]
27. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses.
Castledine C; Casula A; Fogarty D
Nephron Clin Pract; 2012; 120 Suppl 1():c29-54. PubMed ID: 22964573
[TBL] [Abstract][Full Text] [Related]
28. Mortality in the Veneto population on renal replacement therapy.
Nordio M; Tessitore N; Feriani M; Rossi B; Virga G; Amici G; Abaterusso C; Antonucci F;
J Nephrol; 2013; 26 Suppl 20():S23-33. PubMed ID: 24293195
[TBL] [Abstract][Full Text] [Related]
29. Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.
Tsakiris D; Simpson HK; Jones EH; Briggs JD; Elinder CG; Mendel S; Piccoli G; dos Santos JP; Tognoni G; Vanrenterghem Y; Valderrabano F
Nephrol Dial Transplant; 1996; 11 Suppl 7():4-20. PubMed ID: 9067983
[TBL] [Abstract][Full Text] [Related]
30. UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses.
Gilg J; Pruthi R; Fogarty D
Nephron; 2015; 129 Suppl 1():1-29. PubMed ID: 25695805
[TBL] [Abstract][Full Text] [Related]
31. UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses.
Gilg J; Castledine C; Fogarty D; Feest T
Nephron Clin Pract; 2011; 119 Suppl 2():c1-25. PubMed ID: 21894028
[TBL] [Abstract][Full Text] [Related]
32. International comparison of UK registry data (chapter 17).
Caskey F; Steenkamp R; Ansell D
Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii185-93. PubMed ID: 17724048
[TBL] [Abstract][Full Text] [Related]
33. UK Renal Registry 12th Annual Report (December 2009): chapter 13: the UK Renal Registry advanced CKD study: frequency of incorrect reporting of date of start of RRT.
Ford DJ; Fogarty DG; Steenkamp R; Tomson CR; Ben-Shlomo Y; Ansell D
Nephron Clin Pract; 2010; 115 Suppl 1():c271-8. PubMed ID: 20413951
[TBL] [Abstract][Full Text] [Related]
34. Regional and social inequalities in chronic renal replacement therapy in Denmark.
Hommel K; Rasmussen S; Kamper AL; Madsen M
Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
[TBL] [Abstract][Full Text] [Related]
35. UK Renal Registry 16th annual report: chapter 6 demographics and outcomes of patients from different ethnic groups on renal replacement therapy in the UK.
Udayaraj U; Pruthi R; Casula A; Roderick P
Nephron Clin Pract; 2013; 125(1-4):111-25. PubMed ID: 24662170
[TBL] [Abstract][Full Text] [Related]
36. Chapter 11 Clinical, haematological and biochemical parameters in patients receiving renal replacement therapy in paediatric centres in the UK in 2010: national and centre-specific analyses.
Pruthi R; Maxwell H; Casula A; Tse Y; Sinha MD; O'Brien C; Lewis M; Inward C
Nephron Clin Pract; 2012; 120 Suppl 1():c219-32. PubMed ID: 22964569
[TBL] [Abstract][Full Text] [Related]
37. The Challenges of Using UK Renal Registry Data to Audit the Care of Patients with Diabetes on Renal Replacement Therapy.
Cox L; Wong E; Evans KM; Medcalf J; Pyart R
Nephron; 2020; 144(9):440-446. PubMed ID: 32698181
[TBL] [Abstract][Full Text] [Related]
38. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
39. UK Renal Registry 11th Annual Report (December 2008): Chapter 15 The UK Renal Registry, UKRR database, validation and methodology.
Ansell D; Tomson CR
Nephron Clin Pract; 2009; 111 Suppl 1():c277-85. PubMed ID: 19542703
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
Shaw C; Simms RJ; Pitcher D; Sandford R
Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
